1,514
Views
9
CrossRef citations to date
0
Altmetric
Research paper

AZD3759 inhibits glioma through the blockade of the epidermal growth factor receptor and Janus kinase pathways

, , , , , & show all
Pages 8679-8689 | Received 21 Jul 2021, Accepted 05 Oct 2021, Published online: 25 Oct 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Jia Zhang, Yibo Yang, Kun Li & Jian Li. (2023) Application of graphene oxide in tumor targeting and tumor therapy. Journal of Biomaterials Science, Polymer Edition 34:18, pages 2551-2576.
Read now
Ruing Zhao, Wei Yin, Qingqing Yu, Yanjiao Mao, Qinghua Deng, Ke Zhang & Shenglin Ma. (2022) AZD3759 enhances radiation effects in non-small-cell lung cancer by a synergistic blockade of epidermal growth factor receptor and Janus kinase-1. Bioengineered 13:1, pages 331-344.
Read now

Articles from other publishers (6)

Shuangshi Fan, Hao Li & Kun Liu. (2024) Molecular prognostic of nine parthanatos death‐related genes in glioma, particularly in COL8A1 identification. Journal of Neurochemistry 168:3, pages 205-223.
Crossref
Safura Pournajaf, Nastaran Afsordeh & Mohammad Hossein Pourgholami. (2024) In vivo C6 glioma models: an update and a guide toward a more effective preclinical evaluation of potential anti-glioblastoma drugs . Reviews in the Neurosciences 35:2, pages 183-195.
Crossref
Qisheng Luo, Junhong Zhuang, Dandan Zheng, Changfeng Miao, Hongcheng Luo, Jun Peng, Chuanhua Zheng, Chengjian Qin, Chuanliu Lan, Meiqin Chen, Ying Xia, Deyou Huang & Zigui Chen. (2023) IGFBP2 from a novel copper metabolism-associated biomarker promoted glioma progression and response to immunotherapy. Frontiers in Immunology 14.
Crossref
Guang Xia, Song Wu, Ke Luo & Xiaoyu Cui. (2023) By using machine learning and in vitro testing, SERPINH1 functions as a novel tumorigenic and immunogenic gene and predicts immunotherapy response in osteosarcoma. Frontiers in Oncology 13.
Crossref
Hao Wu, Min Wei, Yuping Li, Qiang Ma & Hengzhu Zhang. (2022) Research Progress on the Regulation Mechanism of Key Signal Pathways Affecting the Prognosis of Glioma. Frontiers in Molecular Neuroscience 15.
Crossref
Xiangpan Li, Kewei Xiong, Dong Bi & Chen Zhao. (2022) A Novel CRISPR/Cas9 Screening Potential Index for Prognostic and Immunological Prediction in Low-Grade Glioma. Frontiers in Genetics 13.
Crossref